Samsung plans to bring this early cancer detection test to Asia
Samsung C&T (SCT), Samsung Electronics (SEC), and GRAIL have signed a deal to bring GRAIL’s Galleri multi-cancer early detection (MCED) test to key Asian markets. Initially, they will offer the test in South Korea, and later, if possible, in Japan and Singapore. GRAIL is an American biotechnology company and is focused on developing tests for […]
Read More